This stem celli meeting, held in Lugano, Switzerland, has a particular emphasis on cardiovascular disease. 

The first day focuses on GMP regulation of stem cell therapies and process manufacturing. The second day is dedicated to the latest benchmarking and some ongoing clinical trials focusing on cellular therapy after acute STEMI and in chronic ischemic diseases. The meeting concludes with a discussion about present controversies and future challenges.

Register for one day or both - for full details see the programme and registration form on the Cardiocentro Ticino website